Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Kupffer cells (KCs) rapidly remove intravenously injected adenovirus (Ad) vectors from the circulation. A better understanding of the mechanisms involved could suggest strategies to improve Ad gene delivery by suppressing or evading KC uptake. We recently showed that clearance of Ad type 5 vectors by KCs does not involve the interaction of Ad with the well-established Ad receptors, namely, integrins or the coxsackievirus and Ad receptor (J. S. Smith, Z. Xu, J. Tian, S. C. Stevenson, and A. P. Byrnes, Hum. Gene Ther. 19:547-554, 2008). In the current study, we systematically quantified the contributions of various receptors and plasma proteins to the clearance of Ad by KCs. We found that scavenger receptors are a predominant mechanism for the clearance of Ad by KCs. In addition, we found that Ad is opsonized by natural immunoglobulin M antibodies and complement and that these opsonins play a contributory role in the clearance of Ad by KCs. We also examined additional mechanisms that have been postulated to be involved in the clearance of Ad, including the binding of Ad to platelets and vitamin K-dependent coagulation factors, but we found that neither of these were required for the clearance of Ad by KCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies
Ochsenbein, A. F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner, H., & Zinkernagel, R. M. (1999) · Science · doi:10.1126/science.286.5447.2156 · Cited by 910 · cited 2×
“Similar findings have previously been made with a number of other viruses (21, 22, 37, 61).”
BackgroundResultRole of Kupffer cells in host defense and liver disease
Bilzer, M., Roggel, F., & Gerbes, A. L. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01342.x · Cited by 856 · cited 1×
“One of the most important physiological roles of KCs is to scavenge invading pathogens such as viruses and bacteria and remove them from the blood (7).”
BackgroundAdenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
Waddington, S. N., McVey, J. H., Bhella, D., Parker, A. L., Barker, K., Atoda, H., Pink, R., Buckley, S. M. K., Greig, J. A., Denby, L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.01.016 · Cited by 643 · cited 3×
“Vitamin K-dependent coagulation factors are not required for KC uptake of Ad. Vitamin K-dependent coagulation factors in the plasma have been shown to facilitate the transduction of hepatocytes by Ad both in vitro and in vivo (24, 39, 45, 59 ).”
BackgroundInfluentialCRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens
Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L., Scales, S. J., Ghilardi, N., & van Lookeren Campagne, M. (2006) · Cell · doi:10.1016/j.cell.2005.12.039 · Cited by 628
Role of natural and immune IgM antibodies in immune responses
Boes, M. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(01)00025-6 · Cited by 602 · cited 2×
“Polyreactive natural IgM antibodies play an important role in the control of viral infections in vivo, where they are a vital innate defense during the early stages of an infection, before the adaptive immune system has mounted an antigen-specific response (8, 37, 38, 69).”
BackgroundInteraction forces between colloidal particles in liquid: Theory and experiment
Liang, Y., Hilal, N., Langston, P., & Starov, V. (2007) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2007.04.003 · Cited by 563 · cited 1×
“Altering the hexon sequences to engineer a neutrally charged capsid might be another strategy to limit SR binding, although there could be practical barriers to producing such Ad vectors, given the vital role that surface charge plays in preventing the aggregation of nanoparticles (30).”
BackgroundNatural antibodies and complement link innate and acquired immunity
Ochsenbein, A. F., & Zinkernagel, R. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01754-0 · Cited by 537 · cited 3×
“Polyreactive natural IgM antibodies play an important role in the control of viral infections in vivo, where they are a vital innate defense during the early stages of an infection, before the adaptive immune system has mounted an antigen-specific response (8, 37, 38, 69).”
BackgroundRecognition and plasma clearance of endotoxin by scavenger receptors
Hampton, R. Y., Golenbock, D. T., Penman, M., Krieger, M., & Raetz, C. R. H. (1991) · Nature · doi:10.1038/352342a0 · Cited by 524 · cited 1×
“the most definitive method available to establish the role of SRs in vivo is to compete clearance by preinjecting known SR ligands (18, 25, 27, 57, 62).”
MethodThe Classical Complement Pathway: Activation and Regulation of the First Complement Component
Cooper, N. R. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60340-5 · Cited by 510 · cited 1×
“Only a single IgM molecule is needed to activate the hemolytic activity of complement, a task that requires roughly 1,000 IgG molecules (11).”
Background(1971) · Toxicon · doi:10.1016/0041-0101(71)90016-x · Cited by 459 · cited 1×
“CVF acts as a C3 convertase and depletes C3 and other complement proteins that are downstream of C3 (10).”
BackgroundKawabata, K., Takakura, Y., & Hashida, M. (1995) · Pharmaceutical Research · doi:10.1023/a:1016248701505 · Cited by 456 · cited 1×
“the most definitive method available to establish the role of SRs in vivo is to compete clearance by preinjecting known SR ligands (18, 25, 27, 57, 62).”
MethodAdenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity
Shayakhmetov, D. M., Gaggar, A., Ni, S., Li, Z.-Y., & Lieber, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7478-7491.2005 · Cited by 427 · cited 6×
“Platelets and coagulation factors have previously been proposed to be involved in the clearance of Ad by KCs (45, 55), so we examined their roles quantitatively in our system.”
BackgroundMethodInfluentialBlood clearance rates of adenovirus type 5 in mice
Alemany, R., Suzuki, K., & Curiel, D. T. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2605 · Cited by 413 · cited 6×
“They deleted a 13residue stretch of acidic residues from the Ad5 hexon to reduce the negative charge of the capsid, but this had no effect on the rate of Ad clearance from the circulation, possibly because the overall charge of the capsid was still negative (2).”
BackgroundResultInfluentialLieber, A., He, C. Y., Meuse, L., Schowalter, D., Kirillova, I., Winther, B., & Kay, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8798-8807.1997 · Cited by 412 · cited 1×
“Sequestration of Ad vector by the RES greatly reduces the ability of Ad to reach other tissues, provokes toxic responses, and triggers a rapid destruction of KCs (31, 32, 44, 56, 68).”
BackgroundFcα/μ receptor mediates endocytosis of IgM-coated microbes
Shibuya, A., Sakamoto, N., Shimizu, Y., Shibuya, K., Osawa, M., Hiroyama, T., Eyre, H. J., Sutherland, G. R., Endo, Y., Fujita, T., et al. (2000) · Nature Immunology · doi:10.1038/80886 · Cited by 388
Zhang, Y., Chirmule, N., Gao, G.-P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0329 · Cited by 376 · cited 1×
“Sequestration of Ad vector by the RES greatly reduces the ability of Ad to reach other tissues, provokes toxic responses, and triggers a rapid destruction of KCs (31, 32, 44, 56, 68).”
BackgroundAdenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
Kalyuzhniy, O., Di Paolo, N. C., Silvestry, M., Hofherr, S. E., Barry, M. A., Stewart, P. L., & Shayakhmetov, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711757105 · Cited by 349 · cited 4×
“This scenario is consistent with recent studies showing that the total amount of Ad sequestered in the liver is unchanged in warfarin-treated mice, as measured by the amount of Ad DNA in the liver at 1 h after Ad injection (24, 60).”
BackgroundResultInfluentialBiochemistry and cell biology of mammalian scavenger receptors
Murphy, J. E., Tedbury, P. R., Homer-Vanniasinkam, S., Walker, J. H., & Ponnambalam, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.036 · Cited by 333 · cited 2×
“There are at least eight different classes of SRs that share little sequence homology, but they all possess the ability to recognize negatively charged materials, without any need for opsonization by plasma proteins (34, 35).”
BackgroundTao, N., Gao, G.-P., Parr, M., Johnston, J., Baradet, T., Wilson, J. M., Barsoum, J., & Fawell, S. E. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0227 · Cited by 321 · cited 3×
“) injection, the efficiency of gene delivery is greatly impaired due to rapid removal of virions by the reticuloendothelial system (RES), particularly by Kupffer cells (KCs) in the liver (2, 56, 63).”
BackgroundParker, A. L., Waddington, S. N., Nicol, C. G., Shayakhmetov, D. M., Buckley, S. M., Denby, L., Kemball-Cook, G., Ni, S., Lieber, A., McVey, J. H., et al. (2006) · Blood · doi:10.1182/blood-2006-04-008532 · Cited by 297 · cited 7×
“To examine whether depleting vitamin-K-dependent coagulation factors would affect the uptake of Ad by KCs, mice were treated with warfarin according to the protocol of Parker et al. ( 39 ).”
BackgroundMethodResultInfluentialCAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
Alemany, R., & Curiel, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301515 · Cited by 294 · cited 2×
“injection (1, 2, 14), and electron microscopy shows that Ad virions are taken up inside KCs at this time point (32).”
BackgroundWillekens, F. L. A., Werre, J. M., Kruijt, J. K., Roerdinkholder-Stoelwinder, B., Groenen-Döpp, Y. A. M., van den Bos, A. G., Bosman, G. J. C. G. M., & van Berkel, T. J. C. (2005) · Blood · doi:10.1182/blood-2004-04-1578 · Cited by 280 · cited 1×
“the most definitive method available to establish the role of SRs in vivo is to compete clearance by preinjecting known SR ligands (18, 25, 27, 57, 62).”
MethodJayasekera, J. P., Moseman, E. A., & Carroll, M. C. (2007) · Journal of Virology · doi:10.1128/jvi.02128-06 · Cited by 264 · cited 2×
“Similar findings have previously been made with a number of other viruses (21, 22, 37, 61).”
BackgroundResultZhang, Y., & Bergelson, J. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12125-12131.2005 · Cited by 258 · cited 1×
“Subsequently, the penton base binds to integrins, which allows the virus to be internalized (67).”
BackgroundMok, H., Palmer, D. J., Ng, P., & Barry, M. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.015 · Cited by 232 · cited 1×
“An alternative strategy may be to modify Ad with nonreactive polymers, which is proving to be an effective method for slowing the clearance of Ad from the circulation (14, 33), likely due to a decreased removal of Ad by KCs (reference 33 and our unpublished observations).”
Adenovirus Serotype 5 Fiber Shaft Influences In Vivo Gene Transfer in Mice
Smith, T. A. G., Idamakanti, N., Rollence, M. L., Marshall-Neff, J., Kim, J., Mulgrew, K., Nemerow, G. R., Kaleko, M., & Stevenson, S. C. (2003) · Human Gene Therapy · doi:10.1089/104303403765255165 · Cited by 215 · cited 1×
“route, an interaction of Ad with CAR and integrins is not required for hepatocyte transduction (1, 49).”
BackgroundPearson, A. M., Rich, A., & Krieger, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53729-7 · Cited by 215
Wolff, G., Worgall, S., van Rooijen, N., Song, W. R., Harvey, B. G., & Crystal, R. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.624-629.1997 · Cited by 210
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
Green, N. K., Herbert, C. W., Hale, S. J., Hale, A. B., Mautner, V, Harkins, R., Hermiston, T., Ulbrich, K., Fisher, K. D., & Seymour, L. W. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302295 · Cited by 204 · cited 2×
“An alternative strategy may be to modify Ad with nonreactive polymers, which is proving to be an effective method for slowing the clearance of Ad from the circulation (14, 33), likely due to a decreased removal of Ad by KCs (reference 33 and our unpublished observations).”
BackgroundRother, R. P., Fodor, W. L., Springhorn, J. P., Birks, C. W., Setter, E., Sandrin, M. S., Squinto, S. P., & Rollins, S. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1345 · Cited by 198 · cited 2×
“In addition, natural antibodies are a major obstacle to in vivo gene therapy with retroviruses, bacteriophage, herpes simplex virus type 1, and baculovirus (21, 42, 51, 52, 61).”
BackgroundProperties and function of polyreactive antibodies and polyreactive antigen-binding B cells
Zhou, Z.-H., Tzioufas, A. G., & Notkins, A. L. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.07.015 · Cited by 194 · cited 4×
“Polyreactive natural IgM antibodies play an important role in the control of viral infections in vivo, where they are a vital innate defense during the early stages of an infection, before the adaptive immune system has mounted an antigen-specific response (8, 37, 38, 69).”
BackgroundInfluentialThe role of scavenger receptors in pathogen recognition and innate immunity
Mukhopadhyay, S., & Gordon, S. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.02.004 · Cited by 191 · cited 2×
“There are at least eight different classes of SRs that share little sequence homology, but they all possess the ability to recognize negatively charged materials, without any need for opsonization by plasma proteins (34, 35).”
BackgroundComplement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors
Zaiss, A. K., Cotter, M. J., White, L. R., Clark, S. A., Wong, N. C. W., Holers, V. M., Bartlett, J. S., & Muruve, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.01990-07 · Cited by 177 · cited 1×
“Although all studies agree that the lectin pathway plays no role, some studies found that only the classical pathway is involved (9, 66 ), other studies found that the alternative but not the classical pathway is involved (4, 23), and an additional study found that both the classical and alternative pathways are invol…”
Nalbantoglu, J., Pari, G., Karpati, G., & Holland, P. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950018409 · Cited by 169 · cited 1×
“These receptors can be important for transduction in vivo when Ad vectors are injected locally (36).”
BackgroundStone, D., Liu, Y., Shayakhmetov, D., Li, Z.-Y., Ni, S., & Lieber, A. (2007) · Journal of Virology · doi:10.1128/jvi.02819-06 · Cited by 169 · cited 5×
“Platelets and coagulation factors have previously been proposed to be involved in the clearance of Ad by KCs (45, 55), so we examined their roles quantitatively in our system.”
BackgroundMethodResultInfluentialVlassara, H., Brownlee, M., & Cerami, A. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.4.1301 · Cited by 155 · cited 1×
“Both poly(A) and heparin are known to inhibit the clearance of distinct subsets of SR ligands, apparently by binding to only a subset of SRs (15, 53, 58, 65).”
BackgroundTerpstra, V., & van Berkel, T. J. C. (2000) · Blood · doi:10.1182/blood.v95.6.2157 · Cited by 153 · cited 1×
“the most definitive method available to establish the role of SRs in vivo is to compete clearance by preinjecting known SR ligands (18, 25, 27, 57, 62).”
MethodImmunoglobulin flexibility in complement activation
Feinstein, A., Richardson, N. E., & Taussig, M. I. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90168-4 · Cited by 136 · cited 1×
“Interestingly, IgM changes shape when bound to multivalent antigens and becomes an extremely effective initiator of the classical complement pathway (5, 13).”
BackgroundRapid Kupffer cell death after intravenous injection of adenovirus vectors
Manickan, E., Smith, J. S., Tian, J., Eggerman, T. L., Lozier, J. N., Muller, J., & Byrnes, A. P. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.007 · Cited by 134
Self-citationComplement activation by recombinant adenoviruses
Cichon, G., Boeckh-Herwig, S., Schmidt, H., Wehnes, E., Müller, T., Pring-Akerblom, P., & Burger, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301611 · Cited by 123 · cited 3×
“One issue with using human material is that individual humans have variable levels of specific anti-Ad antibodies that activate complement via the classical pathway (9).”
BackgroundKobayashi, N., Kuramoto, T., Yamaoka, K., Hashida, M., & Takakura, Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29608-7 · Cited by 116
Schiedner, G., Bloch, W., Hertel, S., Johnston, M., Molojavyi, A., Dries, V., Varga, G., van Rooijen, N., & Kochanek, S. (2003) · Human Gene Therapy · doi:10.1089/104303403322542275 · Cited by 106 · cited 2×
“We and others have previously found using electron microscopy that platelets associate with KCs in the liver soon after the i.v. injection of Ad (32, 44 ).”
BackgroundThe Complement Response Against an Oncolytic Virus Is Species-Specific in Its Activation Pathways
Wakimoto, H., Ikeda, K., Abé, T., Ichikawa, T., Hochberg, F. H., Ezekowitz, R. A. B., Pasternack, M. S., & Chiocca, E. A. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0547 · Cited by 99 · cited 3×
“Similar findings have previously been made with a number of other viruses (21, 22, 37, 61).”
BackgroundResultKiang, A., Hartman, Z. C., Everett, R. S., Serra, D., Jiang, H., Frank, M. M., & Amalfitano, A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.024 · Cited by 92
Jiang, H., Wang, Z., Serra, D., Frank, M. M., & Amalfitano, A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.015 · Cited by 84 · cited 2×
“Several previous in vitro studies with human plasma or serum have shown that Ad5 can bind to and activate complement (4, 9, 23, 41).”
BackgroundLymperopoulos, A., Rengo, G., Zincarelli, C., Soltys, S., & Koch, W. J. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300371 · Cited by 83
Alvarez-Domínguez, C., Carrasco-Marín, E., & Leyva‐Cobián, F. (1993) · Infection and Immunity · doi:10.1128/iai.61.9.3664-3672.1993 · Cited by 78 · cited 1×
“For example, C1-opsonized material can bind to C1q receptors on macrophages (3, 12).”
BackgroundHaisma, H. J., Kamps, J. A. A. M., Kamps, G. K., Plantinga, J. A., Rots, M. G., & Bellu, A. R. (2008) · Journal of General Virology · doi:10.1099/vir.0.83495-0 · Cited by 78 · cited 3×
“showed that poly(I) reduces the transduction of macrophages by Ad in vitro, slows the clearance of Ad from the circulation, and enhances the ability of Ad to transduce hepatocytes in vivo (17).”
BackgroundThe Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction
Baker, A. H., McVey, J. H., Waddington, S. N., Paolo, N. C. D., & Shayakhmetov, D. M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300206 · Cited by 77
Immunological factors that affect the in vivo fate of T7 phage in the mouse
Srivastava, A., Kaido, T., & Carrier, E. (2003) · Journal of Virological Methods · doi:10.1016/j.jviromet.2003.09.009 · Cited by 77
Waddington, S. N., Parker, A. L., Havenga, M. J. E., Nicklin, S. A., Buckley, S. M. K., McVey, J. H., & Baker, A. H. (2007) · Journal of Virology · doi:10.1128/jvi.00663-07 · Cited by 72 · cited 2×
“This scenario is consistent with recent studies showing that the total amount of Ad sequestered in the liver is unchanged in warfarin-treated mice, as measured by the amount of Ad DNA in the liver at 1 h after Ad injection (24, 60 ).”
BackgroundResultYan, J., Větvička, V., Xia, Y., Hanikýřová, M., Mayadas, T. N., & Ross, G. D. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(99)00157-5 · Cited by 70
Interaction of Systemically Delivered Adenovirus Vectors with Kupffer Cells in Mouse Liver
Smith, J. S., Xu, Z., Tian, J., Stevenson, S. C., & Byrnes, A. P. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.004 · Cited by 66 · cited 2×
“Likewise, we recently reported that the sequestration of Ad vector by KCs is completely unaffected when vectors are unable to bind to CAR and integrins (48).”
BackgroundSelf-citationHansen, B., Arteta, B., & Smedsrød, B. H. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020660303855 · Cited by 53 · cited 1×
“Studies with SR KO mice have so far not reported any major impact on the clearance of SR ligands in vivo ( 19 ), most likely due to the presence of multiple additional functionally redundant SRs from different classes.”
BackgroundAppledorn, D., Kiang, A., McBride, A. J., Jiang, H., Seregin, S. S., Scott, J. M., Stringer, R., Kousa, Y. A., Hoban, M., Frank, M. M., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.18 · Cited by 53 · cited 2×
“Several previous in vitro studies with human plasma or serum have shown that Ad5 can bind to and activate complement (4, 9, 23, 41).”
BackgroundHoare, J. M., Waddington, S. N., Thomas, H. C., Coutelle, C., & McGarvey, M. J. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.671 · Cited by 53 · cited 3×
“Similar findings have previously been made with a number of other viruses (21, 22, 37, 61).”
BackgroundResultNeuraminidase‐induced thrombocytopenia in mice: Effects on thrombopoiesis
Stenberg, P. E., Levin, J., Baker, G. R., Mok, Y., & Corash, L. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041470103 · Cited by 43 · cited 1×
“Neuraminidase treatment causes a decrease in the amount of sialic acid on the surfaces of platelets and the subsequent removal of platelets from the circulation (54).”
BackgroundLipid Emulsions Potently Increase Transgene Expression in Hepatocytes after Adenoviral Transfer
Snoeys, J., Mertens, G., Lievens, J., van Berkel, T. J. C., Collen, D., Biessen, E. A. L., & Geest, B. D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.477 · Cited by 42 · cited 1×
“It is also worth noting that SRs have been implicated in the uptake of certain types of liposomes (43), and predosing mice with liposomes can reduce the KC uptake of Ad and enhance hepatocyte transduction in vivo (50).”
BackgroundZinn, K. R., Szalai, A. J., Stargel, A., Krasnykh, V. N., & Chaudhuri, T. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302331 · Cited by 41
Serotype Specificity of Adenovirus Purification Using Anion-Exchange Chromatography
Konz, J., Livingood, R. C., Bett, A. J., Goerke, A. R., Laska, M. E., & Sagar, S. L. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1346 · Cited by 39 · cited 2×
“The serotypes most commonly used for gene therapy— Ad5 and the closely related Ad2—are two of the most negatively charged serotypes ( 28 , 29).”
BackgroundA quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells
Smith, J. S., Xu, Z., & Byrnes, A. P. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.08.009 · Cited by 38 · cited 9×
“grown and purified as described previously (47).”
BackgroundMethodInfluentialSelf-citationPerreau, M., Guérin, M.-C., Drouet, C., & Kremer, E. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300289 · Cited by 38 · cited 2×
“Several previous in vitro studies with human plasma or serum have shown that Ad5 can bind to and activate complement (4, 9, 23, 41).”
BackgroundSpecific Recognition of Protein Carboxy-Terminal Sequences by Natural IgM Antibodies in Normal Serum
Sokoloff, A. V., Bock, I., Zhang, G., Hoffman, S. M., Dama, J. F., Ludtke, J. J., Cooke, A., & Wolff, J. A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0340 · Cited by 19 · cited 2×
“In addition, natural antibodies are a major obstacle to in vivo gene therapy with retroviruses, bacteriophage, herpes simplex virus type 1, and baculovirus (21, 42, 51, 52, 61).”
BackgroundMolecular Weight Dependency in the Uptake of Fractionated (3H)Heparin in Isolated Rat Kupffer Cells.
Haba, M., Urano, K., Yuasa, H., & WATANABE, J. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.864 · Cited by 9 · cited 1×
“Both poly(A) and heparin are known to inhibit the clearance of distinct subsets of SR ligands, apparently by binding to only a subset of SRs (15, 53, 58, 65).”
BackgroundAre Novel Scavenger-Like Receptors Involved in the Hepatic Uptake of Heparin?
Yuasa, H., & Watanabe, J. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.273 · Cited by 8 · cited 1×
“Both poly(A) and heparin are known to inhibit the clearance of distinct subsets of SR ligands, apparently by binding to only a subset of SRs (15, 53, 58, 65).”
Background
Cited by
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
Adenovirus receptors: implications for targeting of viral vectors
Arnberg, N. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.005 · Cited by 201
Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
S. Ahi, Y., S. Bangari, D., & K. Mittal, S. (2011) · Current Gene Therapy · doi:10.2174/156652311796150372 · Cited by 185
Adenoviruses as gene/vaccine delivery vectors: Promises and pitfalls
Appaiahgari, M. B., & Vrati, S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.993374 · Cited by 110
“1 Blood factors and preexisting immunity Soon after IV administration, HAd5-based recombinant virus comes in contact with several blood factors [46].”
BackgroundInnate immunity to adenovirus: lessons from mice
Atasheva, S., Yao, J., & Shayakhmetov, D. M. (2019) · FEBS Letters · doi:10.1002/1873-3468.13696 · Cited by 87
Metadata
- Authors
- Xu, Z., Tian, J., Smith, J. S., & Byrnes, A. P.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-12
- Volume
- 82
- Issue
- 23
- Pages
- 11705-11713
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2159716826
- Cited by
- 199
- References
- 65
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.